The latest gynaecological cancer news
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly…
A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through…
University of Virginia Cancer Centre researchers (USA) have explained the failure of immune checkpoint therapy…
Pharma and GmbH announced today that the UK’s National Institute of Health and Care Excellence…
A new report highlights the overwhelming economic and societal cost of ovarian cancer in Australia.…
In a randomised clinical trial, researchers from Huntsman Cancer Institute at the University of Utah, USA, (the U)…
A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced…
A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients…
It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy,…
GSK plc announced today that the European Commission has approved dostarlimab in combination with chemotherapy…